Fulgent Genetics receives Investment Bank Analyst Rating Update
- ByInvesting.com-
Symbol | Exchange | Currency |
|---|
Investing.com - Fulgent Genetics (NASDAQ:FLGT) reported on Monday third quarter earnings that missed analysts' forecasts and revenue that topped expectations. Fulgent Genetics...
Fulgent Genetics, Inc. (FLGT) reported Q3 EPS of $0.06, $0.11 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $105.66 million versus the consensus...
Investors are concerned about high inflation and aggressive rate hikes, even as they gear up for upcoming earnings While large and mid caps garner most of the attention during...
Small cap (market cap between $300 million to $2 billion) are perfect for investors who want to generate higher returns and have a high risk tolerance level. Such stocks are...
Wall Street pays attention to the month of January as a potential predictor of equity returns for the remainder of the year. According to the concept known as the "January effect,"...
Fulgent Genetics, Inc. is a technology company, which offers COVID-19 testing services, molecular diagnostic testing services and comprehensive genetic testing designed to provide physicians and patients with clinically actionable diagnostic information to improve the patient care quality. The Company develops a technology platform, which offers a test menu. It performs full-gene sequencing with deletion/duplication analysis in single-gene tests; pre-established, multi-gene, disease-specific panels; and customized panels. Its test offerings also include Solid Tumor Molecular Profiling for somatic cancer testing, Rapid Whole Genome testing developed for children in neonatal intensive care units or pediatric intensive care units its Newborn Genetic Analysis panel, and a single front-line test designed to comprehensively detect ataxia-related variants. It also offers certain research service tests, which are ordered by research institutions and other similar institutional customers.
| Average | 45.00 (+35.18% Upside) |
| High | 50.00 |
| Low | 40.00 |
| Price | 33.29 |
| No. of Analysts | 3 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Buy | Sell |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 30.09 | 30.11 | 29.33 | +0.39 | +1.31% | 46.35M | NASDAQ | |||
| 224.71 | 227.08 | 223.67 | -0.19 | -0.08% | 6.72M | NYSE | |||
| 99.16 | 99.21 | 96.82 | +2.43 | +2.51% | 23.94M | NASDAQ | |||
| 93.45 | 94.28 | 92.64 | +1.04 | +1.13% | 14.32M | NYSE | |||
| 160.27 | 161.42 | 154.76 | +15.84 | +10.97% | 232.88M | NASDAQ | |||
| 8.19 | 8.41 | 8.12 | -0.17 | -2.03% | 6.94M | NYSE | |||
| 226.72 | 235.36 | 217.48 | +12.90 | +6.03% | 2.29M | NASDAQ | |||
| 248.00 | 248.31 | 242.00 | +7.39 | +3.07% | 33.13M | NASDAQ | |||
| 108.47 | 108.49 | 107.18 | +0.97 | +0.90% | 762.88K | NYSE | |||
| 48.01 | 48.05 | 47.03 | +1.40 | +3.00% | 297.96K | NASDAQ | |||
| 6.13 | 6.58 | 6.06 | -0.10 | -1.61% | 11.36M | NASDAQ | |||
| 410.39 | 412.65 | 401.42 | +6.63 | +1.64% | 1.82M | NASDAQ | |||
| 114.10 | 114.69 | 112.30 | -2.06 | -1.77% | 1.87M | NYSE | |||
| 428.76 | 429.46 | 415.00 | +6.14 | +1.45% | 1.56M | NASDAQ | |||
| 120.57 | 121.30 | 118.76 | +0.32 | +0.27% | 10.00M | NYSE |